BCG immunotherapy of bladder cancer: 20 years on
@article{Alexandroff1999BCGIO, title={BCG immunotherapy of bladder cancer: 20 years on}, author={A. Alexandroff and A. Jackson and M. O'Donnell and K. James}, journal={The Lancet}, year={1999}, volume={353}, pages={1689-1694} }
1The situation is similar for most industrialised western nations, with incidence rates of 18 to 30 new cases per 10 0 000 men placing bladder cancer among the top five cancers in this sex. It is unclear why women are affected a third to a quarter less often than men. In 75% of patients the disease is diagnosed in its early superficial stage, usually as a result of gross or microscopic blood in the urine. However, with an overall 65% recurrence rate and 30% progression rate, even these patients… CONTINUE READING
Topics from this paper
426 Citations
Possible disease remission in patient with invasive bladder cancer with D-fraction regimen
- Medicine
- International journal of general medicine
- 2009
- 5
- PDF
Medical Management of Patients with Refractory Carcinoma In Situ of the Bladder
- Medicine
- Drugs & aging
- 2001
- 16
Molecular followup of newly diagnosed bladder cancer using urine samples.
- Medicine
- The Journal of urology
- 2001
- 14
References
SHOWING 1-10 OF 40 REFERENCES
Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.
- Medicine
- The Journal of urology
- 1980
- 224
Intravesical BCG: Current results, natural history and implicants for urothelial cancer prevention
- Medicine
- Journal of cellular biochemistry. Supplement
- 1992
- 39
Megadose vitamins in bladder cancer: a double-blind clinical trial.
- Medicine
- The Journal of urology
- 1994
- 168
Bacillus Calmette-Guérin immunotherapy for superficial bladder cancer. New prospects for an old warhorse.
- Medicine
- Surgical oncology clinics of North America
- 1995
- 49
Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndrome analysis.
- Medicine
- The Journal of urology
- 1998
- 50
Prediction of response to treatment in superficial bladder carcinoma through pattern of interleukin-2 gene expression.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 1996
- 87
Apparent failure of current intravesical chemotherapy prophylaxis to influence the long-term course of superficial transitional cell carcinoma of the bladder.
- Medicine
- The Journal of urology
- 1995
- 192
Expression of mage genes in transitional‐cell carcinomas of the urinary bladder
- Biology, Medicine
- International journal of cancer
- 1995
- 145